Release Date: 31/01/17 19:12 Summary: Quarterly Activities & Cashflow Report Price Sensitive: Yes Download Document 542.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%